ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

TRIB Trinity Biotech PLC

1.68
-0.07 (-4.00%)
Fuera de horario
Última actualización: 18:05:26
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Trinity Biotech PLC TRIB NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.07 -4.00% 1.68 18:05:26
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.81 1.68 1.87 1.68 1.75
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/4/202406:30GLOBETrinity Biotech Announces Fourth Quarter and Fiscal Year..
28/3/202417:39GLOBETrinity Biotech plc to Announce Q4 and Fiscal Year 2023..
08/3/202409:03GLOBETrinity Biotech Regains Compliance with Nasdaq Minimum..
15/2/202413:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/2/202411:34GLOBETrinity Biotech Plc Finalizes Effective Date of ADS Ratio..
13/2/202408:00GLOBETrinity Biotech Plc Announces Plan to Implement ADS Ratio..
09/2/202418:51EDGAR2Form SC 13D - General statement of acquisition of beneficial..
08/2/202407:30GLOBETrinity Biotech to Present at Emerging Growth Conference
07/2/202407:30GLOBETrinity Biotech Announces Application for Early Sjogrens..
01/2/202410:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/2/202410:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202406:05GLOBETrinity Biotech Announces Q3 2023 Financial Results &..
31/1/202406:02GLOBETrinity Biotech Announces Entry into a Letter of Intent with..
31/1/202406:00GLOBETrinity Biotech Announces Acquisition of the CGM Assets of..
30/1/202416:23GLOBETrinity Biotech plc to Host Investor Call
02/1/202415:17EDGAR2Form SC 13D/A - General statement of acquisition of..
02/1/202415:13EDGAR2Form SC 13D/A - General statement of acquisition of..
02/1/202413:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202307:57GLOBETrinity Biotech Announces It Has Begun Shipments of Its New..
19/12/202312:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/202315:30GLOBETrinity Biotech Announces Management Changes
29/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202315:05GLOBETrinity Biotech Receives Non-Compliance Notice Regarding..
10/10/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202307:15GLOBETrinity Biotech Welcomes The Decision Of The High Court Of..
06/10/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202308:15GLOBETrinity Biotech Announces Q2 2023 Financial Results
03/10/202306:58IHMARKETNEWSTuesday’s Wall Street Highlights: GM, Airbnb, Tesla, Apple,..
27/9/202311:50GLOBETrinity Biotech plc to Announce Second Quarter Fiscal Year..
12/9/202315:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202315:50GLOBETrinity Biotech Receives Non-Compliance Notice Regarding..
06/9/202315:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202314:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202307:00GLOBETrinity Biotech Announces That It Has Received 510(k)..
10/7/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202308:45GLOBETrinity Biotech Announces Q1 2023 Financial Results
03/7/202317:30GLOBETrinity Biotech plc to Announce First Quarter Fiscal Year..
05/5/202307:00GLOBETrinity Biotech Regains Compliance with Nasdaq Minimum..

Su Consulta Reciente

Delayed Upgrade Clock